The Dales Report | Trade to Black

A major shakeup at the Department of Justice is now front and center — and it could have real implications for cannabis rescheduling.In the latest Trade To Black podcast, presented by Flowhub, Shadd Dales and Anthony Varrell are joined by Michael Bronstein, President of the American Trade Association for Cannabis and Hemp (ATACH), to break down what Pam Bondi’s firing means for U.S. cannabis policy.With Bondi out, Acting Attorney General Todd Blanche has stepped in. At the same time, EPA Administrator Lee Zeldin is being mentioned as the leading candidate for the permanent role.The key question is simple — does this speed up rescheduling, or does it slow things down?Trump’s December 18, 2025 executive order directed the DOJ to move cannabis from Schedule I to Schedule III. That would eliminate 280E, expand research, and bring more clarity to the industry. But the timeline now depends on who is leading the DOJ and how they approach the process.Blanche is seen as someone who can keep things moving. Zeldin is viewed as more cautious, with a stronger focus on states’ rights and a narrower approach to reform.The episode also touches on Trump’s proposal to continue protecting state-level medical cannabis programs, while still blocking recreational sales in Washington, D.C., along with growing momentum in North Carolina around legalization.This is where things stand right now — policy direction is set, but execution is what matters next.#CannabisNews #CannabisPolicy #DOJ #CannabisStocks #Rescheduling #Trump #CannabisIndustry #ATACH #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬    • White House Signals Cannabis Enforcement S...  🎬    • Dr. Oz Pushes CBD Into Medicare | TDR Cann...  🎬    • Five Positive Cannabis Trends in 2026 | TD...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

A major shift is taking place in Washington — and this time, it’s focused on enforcement.In this episode of TDR Cannabis in 5, presented by Flowhub, Shadd Dales breaks down what came out of the first-ever White House meeting focused specifically on cannabis and hemp product enforcement.After years of fragmented oversight, federal agencies including the FDA and DOJ are now actively working toward a coordinated enforcement framework — and the tone has clearly shifted from observation to action.At the center of the discussion is a proposed FDA policy focused on CBD product compliance, covering areas like testing standards, labeling requirements, and product safety. But the bigger story goes beyond CBD.This meeting also put a spotlight on intoxicating hemp-derived products like delta-8, which continue to operate in a gray area outside of regulated cannabis systems. Concerns around consumer safety, inconsistent dosing, and marketing practices — especially those targeting younger audiences — were front and center.The key takeaway is simple: federal regulators are preparing to step in and bring structure to a market that has grown rapidly with limited oversight.While timelines and enforcement details are still unclear, the direction is becoming more defined.For the industry, this creates a clear divide between companies already focused on compliance — and those that have relied on regulatory gaps.And as enforcement ramps up, that gap is likely to become more visible.#CannabisNews #CBD #Hemp #CannabisPolicy #FDA #DOJ #CannabisIndustry #CannabisRegulation #HempIndustry #CannabisInvestingWant to see more Cannabis Reform videos?🎬    • Dr. Oz Pushes CBD Into Medicare | TDR Cann...  🎬    • Five Positive Cannabis Trends in 2026 | TD...  🎬    • Cannabis Rescheduling Back in Focus After ...  🎬    • SAM Lawsuit Targets CBD Medicare Program |...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

A major DOJ shakeup, a sweeping hemp crackdown in Texas, and a busy week of earnings across the cannabis sector — this recap covers it all.In the latest Trade To Black podcast, presented by FRE Nicotine Pouches, host Shadd Dales break down one of the most eventful weeks the industry has seen in some time.The episode starts in Washington, where President Trump has fired Attorney General Pam Bondi, with Todd Blanche stepping in as acting AG. With cannabis rescheduling still unresolved, any instability at the Department of Justice raises new questions around timing and execution at the federal level.From there, the focus shifts to Texas, where new hemp rules are now in effect — pushing smokable products off shelves and dramatically increasing compliance costs. The changes are already impacting operators, with some businesses shutting down and others bracing for major revenue declines.On the business side, several key companies reported updates. Jushi Holdings (CSE: JUSH) (OTCQX: JUSHF) posted steady results and completed a major debt refinancing, while Tilray (NASDAQ: TLRY) (TSX: TLRY) delivered record revenue but faced investor concerns around its beverage strategy.Other developments include continued growth from Grown Rogue (CSE: GRIN) (OTCQX: GRUSF), aggressive M&A activity from Vireo Growth (CSE: VREO) (OTCQX: VREOF), improved debt terms for Village Farms (NASDAQ: VFF) (TSX: VFF), and international momentum from MediPharm Labs (TSX: LABS) (OTCQX: MEDIF).Across policy and performance, this week highlights a clear theme — the cannabis industry is evolving, but execution and structure are starting to matter more than ever.If you’re looking for a cleaner way to stay focused, visit frepouch.com and use promo code TDR20 to save $20 on your first order.#CannabisNews #CannabisStocks #CannabisIndustry #DOJ #Hemp #Tilray #Jushi #CannabisInvesting #TDR #PamBondi #PresidentTrump #CannabisReschedulingWant to see more Cannabis Reform videos?🎬    • Dr. Oz Pushes CBD Into Medicare | TDR Cann...  🎬    • Five Positive Cannabis Trends in 2026 | TD...  🎬    • Cannabis Rescheduling Back in Focus After ...  🎬    • SAM Lawsuit Targets CBD Medicare Program |...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

A major shift is happening in Washington — and this time, it directly involves federal healthcare.In this episode of TDR Cannabis in 5, presented by Flowhub, Shadd Dales breaks down the launch of a new Medicare-backed pilot program led by Dr. Mehmet Oz that will allow coverage for hemp-derived CBD products — with the potential to expand into THC-related products over time.This marks a significant moment for the cannabis industry.For the first time, the U.S. government is not just regulating cannabinoids — it’s stepping in as a payer, helping fund access for patients through Medicare. The program is expected to begin as early as April and could provide coverage of up to $500 per year for eligible patients, primarily seniors.But this isn’t just about access.It introduces a new framework built around compliance, safety, and medical oversight. Products will need to meet strict standards for testing, labeling, and consistency — something the broader hemp market has struggled with for years.At the same time, there are still key unknowns around supplier approvals, qualifying conditions, and how distribution will work in practice.For operators and investors, this represents a structural shift — moving cannabinoids closer to a healthcare-driven model rather than a traditional retail one.And with that shift comes opportunity — but also higher barriers to entry.#CannabisNews #CBD #Medicare #CannabisPolicy #Hemp #CannabisIndustry #CannabisInvesting #TDR #Healthcare #CannabisStocksWant to see more Cannabis Reform videos?🎬    • Five Positive Cannabis Trends in 2026 | TD...  🎬    • Cannabis Rescheduling Back in Focus After ...  🎬    • SAM Lawsuit Targets CBD Medicare Program |...  🎬    • White House Meetings Signal New CBD Rules ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

Not all cannabis headlines are negative — and this episode takes a step back to focus on what’s actually working.In this special Good Friday edition of TDR Cannabis in 5, presented by Flowhub, Shadd Dales highlights five positive developments shaping the cannabis industry so far in 2026.The episode starts with a major shift at the federal level, where CBD policy is finally beginning to take shape through a proposed framework involving the FDA and White House review. While still in progress, it signals a move toward clearer rules around testing, labeling, and product safety.From there, attention turns to cannabis rescheduling. The conversation has now moved beyond speculation and into process, with regulatory steps underway that could ultimately lead to a move to Schedule III — a change that would impact taxes, research, and access to capital.The episode also highlights improving industry fundamentals, as operators shift toward profitability, stronger margins, and better balance sheet management in a more disciplined environment.On the state level, Virginia continues moving closer to adult-use cannabis sales, adding momentum to East Coast expansion.And finally, hemp regulation is now front and center in Washington. While still evolving, the fact that lawmakers and federal agencies are actively engaged signals progress toward a more unified approach to cannabinoids.Taken together, these developments point to an industry that is maturing, stabilizing, and steadily moving forward.#CannabisNews #CannabisIndustry #CBD #CannabisPolicy #CannabisRescheduling #VirginiaCannabis #Hemp #CannabisStocks #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬    • Cannabis Rescheduling Back in Focus After ...  🎬    • SAM Lawsuit Targets CBD Medicare Program |...  🎬    • White House Meetings Signal New CBD Rules ...  🎬    • Congressman Pressures DOJ on Cannabis Resc...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesreport  ✅ Instagram:   / dalesreport  ✅ LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...